blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3524231

EP3524231 - STABILIZED PREPARATION OF INTERFERON BETA VARIANT [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  14.04.2023
Database last updated on 13.04.2024
FormerThe patent has been granted
Status updated on  06.05.2022
FormerGrant of patent is intended
Status updated on  22.02.2022
FormerExamination is in progress
Status updated on  14.05.2021
FormerRequest for examination was made
Status updated on  12.07.2019
FormerThe international publication has been made
Status updated on  14.04.2018
Most recent event   Tooltip23.06.2023Lapse of the patent in a contracting state
New state(s): LU		published on 26.07.2023  [2023/30]
Applicant(s)For all designated states
Abion Inc.
(Gaepo-dong) room 202
Changwon Bldg. 5
Gaepo-ro 34-gil
Gangnam-gu
Seoul 06309 / KR
[2019/33]
Inventor(s)01 / LEE, Heejung
35 Sinnae-ro 7ga-gil
Jungnang-gu
Seoul 02079 / KR
02 / KIM, Nam Ah
108-501
135 Simgok-ro
Seo-gu
Incheon 22714 / KR
 [2019/33]
Representative(s)Dehns
St. Bride's House
10 Salisbury Square
London EC4Y 8JD / GB
[2019/33]
Application number, filing date17858685.528.09.2017
[2019/33]
WO2017KR10826
Priority number, dateKR2016012920806.10.2016         Original published format: KR 20160129208
[2019/33]
Filing languageKO
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2018066891
Date:12.04.2018
Language:KO
[2018/15]
Type: A2 Application without search report 
No.:EP3524231
Date:14.08.2019
Language:EN
[2019/33]
Type: B1 Patent specification 
No.:EP3524231
Date:08.06.2022
Language:EN
[2022/23]
Search report(s)International search report - published on:KR09.08.2018
(Supplementary) European search report - dispatched on:EP12.05.2020
ClassificationIPC:A61K9/08, A61K9/19, A61K47/26, A61K47/18, A61K47/12, A61K47/10, A61K38/21, A61P35/00, A61P37/00, A61P31/12
[2020/24]
CPC:
A61K9/08 (EP,KR,US); A61K47/183 (EP,KR,US); A61K38/21 (EP,US);
A61K38/215 (EP,KR,US); A61K47/10 (EP,KR,US); A61K47/12 (EP,KR,US);
A61K47/18 (US); A61K47/20 (KR); A61K47/26 (EP,KR,US);
A61K9/0029 (US); A61K9/0053 (US); A61K9/19 (EP,KR,US);
A61P31/12 (EP,US); A61P35/00 (EP); A61P37/00 (EP) (-)
Former IPC [2019/33]A61K9/08, A61K9/19, A61K47/26, A61K47/12, A61K47/18, A61K47/10, A61K38/21
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2019/33]
Extension statesBANot yet paid
MENot yet paid
Validation statesMANot yet paid
MDNot yet paid
TitleGerman:STABILISIERTE HERSTELLUNG EINER INTERFERON-BETA-VARIANTE[2019/33]
English:STABILIZED PREPARATION OF INTERFERON BETA VARIANT[2019/33]
French:PRÉPARATION STABILISÉE DE VARIANT D'INTERFÉRON BÊTA[2019/33]
Entry into regional phase01.05.2019Translation filed 
01.05.2019National basic fee paid 
01.05.2019Search fee paid 
01.05.2019Designation fee(s) paid 
01.05.2019Examination fee paid 
Examination procedure01.05.2019Examination requested  [2019/33]
11.12.2020Amendment by applicant (claims and/or description)
18.05.2021Despatch of a communication from the examining division (Time limit: M04)
07.09.2021Reply to a communication from the examining division
23.02.2022Communication of intention to grant the patent
27.04.2022Fee for grant paid
27.04.2022Fee for publishing/printing paid
27.04.2022Receipt of the translation of the claim(s)
Opposition(s)10.03.2023No opposition filed within time limit [2023/20]
Fees paidRenewal fee
26.09.2019Renewal fee patent year 03
30.09.2020Renewal fee patent year 04
24.09.2021Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAL08.06.2022
CZ08.06.2022
EE08.06.2022
HR08.06.2022
LT08.06.2022
LV08.06.2022
MC08.06.2022
NL08.06.2022
RO08.06.2022
RS08.06.2022
SI08.06.2022
SK08.06.2022
SM08.06.2022
BG08.09.2022
NO08.09.2022
LU28.09.2022
IS08.10.2022
[2023/30]
Former [2023/25]AL08.06.2022
CZ08.06.2022
EE08.06.2022
HR08.06.2022
LT08.06.2022
LV08.06.2022
MC08.06.2022
NL08.06.2022
RO08.06.2022
RS08.06.2022
SI08.06.2022
SK08.06.2022
SM08.06.2022
BG08.09.2022
NO08.09.2022
IS08.10.2022
Former [2023/22]AL08.06.2022
CZ08.06.2022
EE08.06.2022
HR08.06.2022
LT08.06.2022
LV08.06.2022
MC08.06.2022
NL08.06.2022
RO08.06.2022
RS08.06.2022
SK08.06.2022
SM08.06.2022
BG08.09.2022
NO08.09.2022
IS08.10.2022
Former [2023/17]AL08.06.2022
CZ08.06.2022
EE08.06.2022
HR08.06.2022
LT08.06.2022
LV08.06.2022
NL08.06.2022
RO08.06.2022
RS08.06.2022
SK08.06.2022
SM08.06.2022
BG08.09.2022
NO08.09.2022
IS08.10.2022
Former [2023/12]CZ08.06.2022
EE08.06.2022
HR08.06.2022
LT08.06.2022
LV08.06.2022
NL08.06.2022
RO08.06.2022
RS08.06.2022
SK08.06.2022
SM08.06.2022
BG08.09.2022
NO08.09.2022
IS08.10.2022
Former [2023/09]CZ08.06.2022
EE08.06.2022
HR08.06.2022
LT08.06.2022
LV08.06.2022
NL08.06.2022
RO08.06.2022
RS08.06.2022
SK08.06.2022
SM08.06.2022
BG08.09.2022
NO08.09.2022
Former [2023/02]HR08.06.2022
LT08.06.2022
LV08.06.2022
NL08.06.2022
RS08.06.2022
BG08.09.2022
NO08.09.2022
Former [2022/50]HR08.06.2022
LT08.06.2022
LV08.06.2022
RS08.06.2022
BG08.09.2022
NO08.09.2022
Former [2022/49]HR08.06.2022
LT08.06.2022
LV08.06.2022
BG08.09.2022
NO08.09.2022
Former [2022/47]LT08.06.2022
NO08.09.2022
Documents cited:Search[Y]EP0948358  (BIOGEN INC [US]) [Y] 1-12 * Claims, in particular claims 32-43 and 58-69; Description, in particular paragraph [2], Table 1 line 1, Table 2, line 2 *;
 [Y]WO02080976  (CHIRON CORP [US], et al) [Y] 1-12 * Claims, in particular claims 1, 13, 15-17; description, in particular page 21 lines 13-32 and page 23 line 19 to page 24 line 3 and example 2 and Figure 11 as well as examples 3-7 *;
 [YA]EP1809661  (SHIN YOUNG KEE [KR]) [Y] 2 * Claims, in particular claims 4, 14 and 16; description, in particular paragraphs [50]-[53] * [A] 1,3-12;
 [Y]EP2234645  (MERCK SERONO SA [CH]) [Y] 1-12* Claims, in particular claims 1, 7, 10, 13 and 16-17; Description, in particular paragraphs [96], [103] und [2] *;
 [Y]WO2015134406  (JOLLA BIOLOG INC [US], et al) [Y] 1-12 * Claims, in particular claims 1, 2, 9-12, 14, 17, 24 and 30; Description *
International search[Y]KR20060039132  (SAMSUNG FINE CHEMICALS CO LTD [KR]) [Y] 2 * See paragraphs [0036]-[0047]; claims 1-3; and figure 1. *;
 [Y]KR20070030855  (ARES TRADING S.A.) [Y] 1-12 * See abstract; pages 32-43; and claims 1-44. *;
 [Y]KR20070052363  (BIOGEN IDEC INC [US]) [Y] 1-12 * See abstract; pages 14-16; and tables 1, 2. *;
 [Y]US2007248674  (DEL CURTO MARIA D [IT], et al) [Y] 1-12 * See abstract; paragraphs [0232]-[0234]; and claims 35-42. *;
 [Y]KR20100099298  (MERCK SERONO SA [CH]) [Y] 1-12* See abstract; paragraphs [0107]-[0132]; and claims 1-26. *
by applicantKR100781666B
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.